HYMPAVZI is already approved in the US for patients 12 and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
The findings, based on an exploratory analysis, indicate that CD47 expression may predict which patients benefit most from the therapy
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
Fid?s brings core strengths across imaging applications and human biology, supporting work in digestive disease, GI oncology, and select solid tumors
The platform uses cutting-edge AI and automation to tackle the entire revenue cycle
The collaboration will center on expanding access to Eastman’s Esmeri technology
The partnership initially will focus on cardiovascular and kidney diseases
Subscribe To Our Newsletter & Stay Updated
